Rouslan Kotchetkov, Vikas K Gupta
Abstract
![Figure][1] A 59-year-old female was diagnosed 13 years earlier with JAK2 617-positive polycythemia vera (PV) and treated with phlebotomies. Recently she developed progressive splenomegaly and decreased needs for phlebotomy. A diagnosis of post–PV-myelofibrosis was considered, but not
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
![Figure][1] A 59-year-old female was diagnosed 13 years earlier with JAK2 617-positive polycythemia vera (PV) and treated with phlebotomies. Recently she developed progressive splenomegaly and decreased needs for phlebotomy. A diagnosis of post–PV-myelofibrosis was considered, but not
Key concepts: Phlebotomy, Polycythemia vera, Myelofibrosis, Medicine, Ruxolitinib, Leukemia, Internal medicine, Gastroenterology